Having pulmonary fibrosis has an impact on many aspects of life. A person may not be able to do as much walking, climb stairs so well, or just becomes tired easily. However, one can still enjoy life and the pleasures of it, such as going…
Drugs targeting a pathway centered on a molecule named PI3K and a mammalian target of rapamycin (mTOR) — another molecule in the same pathway — are in early, preclinical tests in a variety of disease conditions, and recently completed a Phase 1 cancer trial. A study from University College London  also found that…
Professor Jürgen Behr, from the University of Munich, Germany, talks in this video by Boehringer Ingelheim Idiopathic Pulmonary Fibrosis about idiopathic pulmonary fibrosis and how patients can benefit from receiving medical treatment for IPF. Learn more about pulmonary fibrosis: https://bit.ly/1VElTQA…
Patients with pulmonary fibrosis who are active in taking care of their own health, frequently find themselves with better results in the long run. Here are a few notes to help you maximize self-care (source: Pulmonary Fibrosis Foundation website): Reach support groups. There are…
In late 2010, Barbara was diagnosed with idiopathic pulmonary fibrosis. Not having an accurate diagnosis, her doctors decided to star treating her for IPF. Demystifying Medicine shared this video where we can watch Barbara talk about her journey since her diagnosis and addressed common…
Scientists from the Karolinska University Hospital, Sweden, reported findings from the first year of a national registry of idiopathic pulmonary fibrosis patients (IPF), which showed that Swedish IPF patients have a poor quality of life and poor perception of their disease — despite a relatively modest level of disease severity.
In this video by Boehringer Ingelheim Idiopathic Pulmonary Fibrosis, Dr. Toby Maher explains the outlook for patients diagnosed with idiopathic pulmonary fibrosis. He talks about the life expectancy averages after diagnosis, what the future of a patient will be like, advancements in medicine,…
Prof. Daniel Chambers from the Queensland Lung Transplant Service, in The Prince Charles Hospital in Brisbane, Australia, debunks a few myths about lung transplantations with some pulmonary fibrosis  patients and other patients with lung complications: Myth 1. “Lung Transplantations are experimental treatments.” Lung transplantation was revolutionary when it was…
A case report of a woman with pulmonary fibrosis and a rare telomere mutation raised the possibility that telomere-associated fibrosis can be observed without shortened telomeres. The study, “TINF2 Gene Mutation in a Patient with Pulmonary Fibrosis“, published in the journal Case Reports in Pulmonology, proposed that…
Pulmonary fibrosis is a channel dedicated to spreading awareness about this life-threatening heart and lung condition. Meet Mark, a father of two who shares his story of resilience and strength. In 2014, his health began rapidly declining and he found himself limited to his bed for…
Get regular updates to your inbox.
